Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia

H. Cohen S. Green; S. Jones; N. Amos; and B. D. William

首页> 外文期刊>Rheumatology >Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia

【24h】

Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia

机译：利妥昔单抗在原发性混合性冷球蛋白血症患者中缺乏疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Rheumatology》 |2007年第2期|366-367|共2页
作者
H. Cohen S. Green; S. Jones; N. Amos; and B. D. William;
展开▼
作者单位

Department of Rheumatology Royal National Hospital for Rheumatic Diseases Upper Borough Walls Bath BA1 1RL;

Department of Rheumatology Ysbyty Gwynedd Bangor Gwynedd LL57 2PW and;

Department of Rheumatology University Hospital of Wales Heath Park Cardiff Wales CF14 4XW;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids [J] . L. Quartuccio, G. Soardo, G. Romano, Rheumatology . 2006,第7期

机译：利妥昔单抗治疗HCV相关性混合性冰球蛋白血症的肾小球肾炎：在没有类固醇的情况下的有效性和安全性
2. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. [J] . Quartuccio L, Soardo G, Romano G, Rheumatology . 2006,第7期

机译：利妥昔单抗治疗HCV相关性混合性冰球蛋白血症的肾小球肾炎：在没有类固醇的情况下的疗效和安全性。
3. I Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment [J] . Basile Umberto, Gragnani Laura, Piluso Alessia, Liver international : . 2015,第9期

机译：I接受利妥昔单抗治疗的混合性冰球蛋白血症性血管炎的HCV阳性患者的游离轻链评估
4. Successful Treatment of a Patient with High Titer Acquired Factor VIM Inhibitor (114 BU) with Rituximab [C] . Ch. Schubert, M. Herold Hemophilia Symposium . 2008

机译：用Rituximab成功治疗高滴度获得因子Vim抑制剂（114 Bu）的患者
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin’s lymphoma previously treated with interferon [O] . Endri Mauro, Mariangela Pedata, Anna Ermacora, 2012

机译：利妥昔单抗治疗后与丙型肝炎病毒相关的混合性冷球蛋白血症和顽固性非霍奇金淋巴瘤的患者接受利妥昔单抗后聚乙二醇干扰素和利巴韦林的另一种治疗方法
7. Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia [O] . H. Cohen, S. Green, S. Jones, 2006

机译：患有必需混合冷冻蛋白酶血症的患者中戒指缺乏疗效

Lack of efficacy of Rituximab in a patient with essential mixed cryoglobulinaemia

著录项

相似文献

相关主题

期刊订阅